Position in CRSP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,992,414
+$16,208,902 QoQ
Shares Held
879,949
+31.7% QoQ
Ownership
0.910%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. CRSP ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,992,414 | 879,949 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $31,783,512 | 668,142 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,980,623 | 667,060 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $90,595,237 | 1,397,859 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $24,873,517 | 511,380 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $44,238,383 | 1,299,982 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,483,275 | 495,002 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $29,691,495 | 632,003 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $32,280,638 | 597,679 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $74,016,574 | 1,085,924 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $25,858,615 | 413,077 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $15,951,630 | 351,435 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $21,941,754 | 390,840 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,281,885 | 470,526 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,641,781 | 507,793 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $38,284,901 | 585,844 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,484,418 | 567,458 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $32,476,441 | 517,388 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $41,187,183 | 543,510 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $64,921,747 | 580,021 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $84,144,752 | 519,765 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $105,676,601 | 867,268 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $111,988,784 | 731,427 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $42,112,738 | 503,500 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $41,250,891 | 561,313 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $36,112,918 | 851,519 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||